Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
Take it once a day in the morning, on an empty stomach
Theres nothing Simple about it at all
Like other medications containing semaglutide, Wegovy works by mimicking the GLP-1 hormone thats released in the digestive tract in response to eating
0:58 educational video by Novo Nordisk The 58-second explainer breaks down exactly what food noise is
[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Rudrapal M., Khairnar S.J., Khan J., Dukhyil A.B., Ansari M.A., Alomary M.N., Alshabrmi F.M., Palai S., Deb P.K., Devi R